Ignite Creation Date:
2024-05-06 @ 2:13 AM
Last Modification Date:
2024-10-26 @ 11:15 AM
Study NCT ID:
NCT01999582
Status:
COMPLETED
Last Update Posted:
2024-06-24
First Post:
2013-11-26
Brief Title:
A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept ACE-011 in Patients With End-Stage Kidney Disease on Hemodialysis
Sponsor:
Celgene
Organization:
Celgene
Organization Data
Organization:
Celgene
Class:
INDUSTRY
Study ID:
ACE-011-REN-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Celgene
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None